SBI Securities’s Entera Bio ENTX Stock Holding History

SBI Securities’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3	Buy	+1	New	+$3	﹤0.01%	4073
2026 Q2	–	Sell	-2	Closed	-$2	–	4108
2026 Q1	$2	Buy	+2	New	+$3	﹤0.01%	3960
2025 Q4	–	Sell	-1	Closed	-$2	–	4091
2025 Q3	$2	Buy	+1	New	+$2	﹤0.01%	4145

Other funds holding ENTX

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

SBI Securities's ENTX Position: Q3 2026 in Review

SBI Securities opened a new position in Entera Bio (ENTX) in Q3 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #4073 among its holdings. This is a return to the name: SBI Securities previously reported a position in ENTX as recently as Q1 2026.

SBI Securities first reported a position in ENTX in Q3 2025 and has held it in 3 quarters since. 2 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

SBI Securities held 1 share of Entera Bio worth $3 as of Q3 2026.
Entera Bio was a new SBI Securities position in Q3 2026.
Entera Bio made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4073 holding.
SBI Securities first reported a position in Entera Bio in Q3 2025 and has held it in 3 quarters since.
2 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.